These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 25943786

  • 1. Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.
    Sawyer JR, Tian E, Heuck CJ, Johann DJ, Epstein J, Swanson CM, Lukacs JL, Binz RL, Johnson M, Sammartino G, Zangari M, Davies FE, van Rhee F, Morgan GJ, Barlogie B.
    Blood; 2015 Jun 11; 125(24):3756-9. PubMed ID: 25943786
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma.
    Le Baccon P, Leroux D, Dascalescu C, Duley S, Marais D, Esmenjaud E, Sotto JJ, Callanan M.
    Genes Chromosomes Cancer; 2001 Nov 11; 32(3):250-64. PubMed ID: 11579465
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphoma.
    Itoyama T, Nanjungud G, Chen W, Dyomin VG, Teruya-Feldstein J, Jhanwar SC, Zelenetz AD, Chaganti RS.
    Genes Chromosomes Cancer; 2002 Dec 11; 35(4):318-28. PubMed ID: 12378526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chromosome 1 abnormalities in multiple myeloma.
    Marzin Y, Jamet D, Douet-Guilbert N, Morel F, Le Bris MJ, Morice P, Abgrall JF, Berthou C, De Braekeleer M.
    Anticancer Res; 2006 Dec 11; 26(2A):953-9. PubMed ID: 16619492
    [Abstract] [Full Text] [Related]

  • 10. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
    Alpar D, de Jong D, Holczer-Nagy Z, Kajtar B, Savola S, Jakso P, David M, Kosztolanyi S, Kereskai L, Pajor L, Szuhai K.
    Genes Chromosomes Cancer; 2013 Sep 11; 52(9):785-93. PubMed ID: 23720363
    [Abstract] [Full Text] [Related]

  • 11. Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.
    Bahmanyar M, Qi X, Chang H.
    Leuk Res; 2013 Dec 11; 37(12):1726-8. PubMed ID: 24169086
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Different breakage-prone regions on chromosome 1 detected in t(11;14)-positive mantle cell lymphoma cell lines and multiple myeloma cell lines are associated with different tumor progression-related mechanisms.
    Rudolph C, Liehr T, Steinemann D, Emura M, Daibata M, Matsuo Y, Emi N, Abe M, Lai R, Mrasek K, Claussen U, Schlegelberger B.
    Cytogenet Genome Res; 2006 Dec 11; 112(3-4):213-21. PubMed ID: 16484775
    [Abstract] [Full Text] [Related]

  • 14. [Clinical and biological characteristics multiple myeloma with 1q21 amplification].
    Zhong S, Li C, Yi S, Qiu L.
    Zhonghua Yi Xue Za Zhi; 2016 Mar 01; 96(8):615-9. PubMed ID: 26932854
    [Abstract] [Full Text] [Related]

  • 15. 1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens.
    Grzasko N, Hus M, Chocholska S, Pluta A, Hajek R, Dmoszynska A.
    Leuk Lymphoma; 2012 Dec 01; 53(12):2500-3. PubMed ID: 22497640
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cytogenetic study of multiple myeloma].
    Zhang Y, Jiang B, Huang XJ, Shi Y, He Q, Dang H, Qiu JY, Lu DP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb 01; 15(1):76-8. PubMed ID: 17490526
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.
    Inoue J, Otsuki T, Hirasawa A, Imoto I, Matsuo Y, Shimizu S, Taniwaki M, Inazawa J.
    Am J Pathol; 2004 Jul 01; 165(1):71-81. PubMed ID: 15215163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.